Loading [a11y]/accessibility-menu.js
 
BibTex RIS Cite

The effect of adenoid hypertrophy and adenoidectomy in patients on cardiovascular risk reduction

Year 2016, Volume: 26 Issue: 4, 251 - 252, 10.09.2016

Murat Şereflican Fatma Erdem Veysel Yurttaş

References

  • Soyalıç H, Somuk BT, Doğru S, Gürbüzler L, Göktaş G, Eyibilen A. Evaluation of mean platelet volume and its ratio over platelet count in children with obstructive sleep apnea syndrome. Kulak Burun Bogaz Ihtis Derg 2015;25:16-21.
  • Vizioli L, Muscari S, Muscari A. The relationship of mean platelet volume with the risk and prognosis of cardiovascular diseases. Int J Clin Pract 2009;63:1509-15.
  • Chu SG, Becker RC, Berger PB, Bhatt DL, Eikelboom JW, Konkle B, et al. Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta- analysis. J Thromb Haemost 2010;8:148-56.
  • Kucur C, Kulekci S, Zorlu A, Savran B, Oghan F, Yildirim N. Mean platelet volume levels in children with adenoid hypertrophy. J Craniofac Surg 2014;25:e29-31.
  • Cengiz C, Erhan Y, Murat T, Ercan A, Ibrahim S, Ihsan G, et al. Values of mean platelet volume in patients with chronic tonsillitis and adenoid hypertrophy. Pak J Med Sci 2013;29:569-72.
  • Lancé MD, Sloep M, Henskens YM, Marcus MA. Mean platelet volume as a diagnostic marker for cardiovascular disease: drawbacks of preanalytical conditions and measuring techniques. Clin Appl Thromb Hemost 2012;18:561-8.
  • Jackson SR, Carter JM. Platelet volume: laboratory measurement and clinical application. Blood Rev 1993;7:104-13.

Adenoid hipertrofisi ve adenoidektominin hastalarda kardiyovasküler risk azaltımına etkisi

Year 2016, Volume: 26 Issue: 4, 251 - 252, 10.09.2016

Murat Şereflican Fatma Erdem Veysel Yurttaş

References

  • Soyalıç H, Somuk BT, Doğru S, Gürbüzler L, Göktaş G, Eyibilen A. Evaluation of mean platelet volume and its ratio over platelet count in children with obstructive sleep apnea syndrome. Kulak Burun Bogaz Ihtis Derg 2015;25:16-21.
  • Vizioli L, Muscari S, Muscari A. The relationship of mean platelet volume with the risk and prognosis of cardiovascular diseases. Int J Clin Pract 2009;63:1509-15.
  • Chu SG, Becker RC, Berger PB, Bhatt DL, Eikelboom JW, Konkle B, et al. Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta- analysis. J Thromb Haemost 2010;8:148-56.
  • Kucur C, Kulekci S, Zorlu A, Savran B, Oghan F, Yildirim N. Mean platelet volume levels in children with adenoid hypertrophy. J Craniofac Surg 2014;25:e29-31.
  • Cengiz C, Erhan Y, Murat T, Ercan A, Ibrahim S, Ihsan G, et al. Values of mean platelet volume in patients with chronic tonsillitis and adenoid hypertrophy. Pak J Med Sci 2013;29:569-72.
  • Lancé MD, Sloep M, Henskens YM, Marcus MA. Mean platelet volume as a diagnostic marker for cardiovascular disease: drawbacks of preanalytical conditions and measuring techniques. Clin Appl Thromb Hemost 2012;18:561-8.
  • Jackson SR, Carter JM. Platelet volume: laboratory measurement and clinical application. Blood Rev 1993;7:104-13.
There are 7 citations in total.

Details

Primary Language Turkish
Journal Section Letter to Editor
Authors

Murat Şereflican This is me

Fatma Erdem This is me

Veysel Yurttaş This is me

Publication Date September 10, 2016
Published in Issue Year 2016 Volume: 26 Issue: 4

Cite

APA Şereflican, M., Erdem, F., & Yurttaş, V. (2016). Adenoid hipertrofisi ve adenoidektominin hastalarda kardiyovasküler risk azaltımına etkisi. The Turkish Journal of Ear Nose and Throat, 26(4), 251-252.
AMA Şereflican M, Erdem F, Yurttaş V. Adenoid hipertrofisi ve adenoidektominin hastalarda kardiyovasküler risk azaltımına etkisi. Tr-ENT. September 2016;26(4):251-252.
Chicago Şereflican, Murat, Fatma Erdem, and Veysel Yurttaş. “Adenoid Hipertrofisi Ve Adenoidektominin Hastalarda kardiyovasküler Risk azaltımına Etkisi”. The Turkish Journal of Ear Nose and Throat 26, no. 4 (September 2016): 251-52.
EndNote Şereflican M, Erdem F, Yurttaş V (September 1, 2016) Adenoid hipertrofisi ve adenoidektominin hastalarda kardiyovasküler risk azaltımına etkisi. The Turkish Journal of Ear Nose and Throat 26 4 251–252.
IEEE M. Şereflican, F. Erdem, and V. Yurttaş, “Adenoid hipertrofisi ve adenoidektominin hastalarda kardiyovasküler risk azaltımına etkisi”, Tr-ENT, vol. 26, no. 4, pp. 251–252, 2016.
ISNAD Şereflican, Murat et al. “Adenoid Hipertrofisi Ve Adenoidektominin Hastalarda kardiyovasküler Risk azaltımına Etkisi”. The Turkish Journal of Ear Nose and Throat 26/4 (September 2016), 251-252.
JAMA Şereflican M, Erdem F, Yurttaş V. Adenoid hipertrofisi ve adenoidektominin hastalarda kardiyovasküler risk azaltımına etkisi. Tr-ENT. 2016;26:251–252.
MLA Şereflican, Murat et al. “Adenoid Hipertrofisi Ve Adenoidektominin Hastalarda kardiyovasküler Risk azaltımına Etkisi”. The Turkish Journal of Ear Nose and Throat, vol. 26, no. 4, 2016, pp. 251-2.
Vancouver Şereflican M, Erdem F, Yurttaş V. Adenoid hipertrofisi ve adenoidektominin hastalarda kardiyovasküler risk azaltımına etkisi. Tr-ENT. 2016;26(4):251-2.